• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触激活系统与因子XI的细胞受体和辅助因子相互作用

Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.

作者信息

Pathak Monika, Kaira Bubacarr Gibril, Slater Alexandre, Emsley Jonas

机构信息

Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.

出版信息

Front Med (Lausanne). 2018 Mar 21;5:66. doi: 10.3389/fmed.2018.00066. eCollection 2018.

DOI:10.3389/fmed.2018.00066
PMID:29619369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5871670/
Abstract

The contact activation system (CAS) or contact pathway is central to the crosstalk between coagulation and inflammation and contributes to diverse disorders affecting the cardiovascular system. CAS initiation contributes to thrombosis but is not required for hemostasis and can trigger plasma coagulation the intrinsic pathway [through factor XI (FXI)] and inflammation bradykinin release. Activation of factor XII (FXII) is the principal starting point for the cascade of proteolytic cleavages involving FXI, prekallikrein (PK), and cofactor high molecular weight kininogen (HK) but the precise location and cell receptor interactions controlling these reactions remains unclear. FXII, PK, FXI, and HK utilize key protein domains to mediate binding interactions to cognate cell receptors and diverse ligands, which regulates protease activation. The assembly of contact factors has been demonstrated on the cell membranes of a variety of cell types and microorganisms. The cooperation between the contact factors and endothelial cells, platelets, and leukocytes contributes to pathways driving thrombosis yet the basis of these interactions and the relationship with activation of the contact factors remains undefined. This review focuses on cell receptor interactions of contact proteins and FXI to develop a cell-based model for the regulation of contact activation.

摘要

接触激活系统(CAS)或接触途径是凝血与炎症之间相互作用的核心,并且与影响心血管系统的多种疾病相关。CAS的启动会导致血栓形成,但并非止血所必需,并且可以触发血浆凝血(内源性途径[通过因子XI(FXI)])和炎症(缓激肽释放)。因子XII(FXII)的激活是涉及FXI、前激肽释放酶(PK)和辅因子高分子量激肽原(HK)的蛋白水解裂解级联反应的主要起始点,但控制这些反应的精确位置和细胞受体相互作用仍不清楚。FXII、PK、FXI和HK利用关键蛋白结构域介导与同源细胞受体和多种配体的结合相互作用,从而调节蛋白酶激活。已经在多种细胞类型和微生物的细胞膜上证实了接触因子的组装。接触因子与内皮细胞、血小板和白细胞之间的协同作用促成了驱动血栓形成的途径,但这些相互作用的基础以及与接触因子激活的关系仍不明确。本综述重点关注接触蛋白和FXI的细胞受体相互作用,以建立一个基于细胞的接触激活调节模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ddb/5871670/1f98570429d4/fmed-05-00066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ddb/5871670/4eabacbf3154/fmed-05-00066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ddb/5871670/1f98570429d4/fmed-05-00066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ddb/5871670/4eabacbf3154/fmed-05-00066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ddb/5871670/1f98570429d4/fmed-05-00066-g002.jpg

相似文献

1
Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.接触激活系统与因子XI的细胞受体和辅助因子相互作用
Front Med (Lausanne). 2018 Mar 21;5:66. doi: 10.3389/fmed.2018.00066. eCollection 2018.
2
High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.高分子量激肽原与同源物前激肽释放酶和因子 XI 的相互作用:对表面诱导的凝血的重要性。
J Thromb Haemost. 2024 Jan;22(1):225-237. doi: 10.1016/j.jtha.2023.09.027. Epub 2023 Oct 9.
3
Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.阻断高分子量激肽原的结构域6以了解内源性凝血机制。
Res Pract Thromb Haemost. 2022 Oct 13;6(7):e12815. doi: 10.1002/rth2.12815. eCollection 2022 Oct.
4
Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.血浆激肽释放酶结构揭示与因子 XI 相比,苹果域盘旋转构象。
J Thromb Haemost. 2019 May;17(5):759-770. doi: 10.1111/jth.14418. Epub 2019 Mar 19.
5
Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.抗-HK 抗体通过阻断血浆接触系统中激肽原和因子 XI 的激活来抑制体内的血浆接触系统。
Blood Adv. 2023 Apr 11;7(7):1156-1167. doi: 10.1182/bloodadvances.2021006485.
6
Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.固定化过渡金属离子可刺激接触激活,并驱动因子 XII 介导的凝血。
J Thromb Haemost. 2012 Oct;10(10):2108-15. doi: 10.1111/j.1538-7836.2012.04890.x.
7
Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.核酸作为因子XI和前激肽释放酶激活的辅助因子:高分子量激肽原的不同作用。
Thromb Haemost. 2017 Apr 3;117(4):671-681. doi: 10.1160/TH16-09-0691. Epub 2017 Jan 26.
8
Contact pathway of coagulation and inflammation.凝血和炎症的接触途径。
Thromb J. 2015 May 6;13:17. doi: 10.1186/s12959-015-0048-y. eCollection 2015.
9
Titanium is a potent inducer of contact activation: implications for intravascular devices.钛是一种有效的接触激活诱导剂:对血管内装置的影响。
J Thromb Haemost. 2023 May;21(5):1200-1213. doi: 10.1016/j.jtha.2022.12.014. Epub 2022 Dec 22.
10
The complex role of kininogens in hereditary angioedema.激肽原在遗传性血管性水肿中的复杂作用。
Front Allergy. 2022 Aug 3;3:952753. doi: 10.3389/falgy.2022.952753. eCollection 2022.

引用本文的文献

1
A model of zymogen factor XII: insights into protease activation.凝血因子XII酶原模型:对蛋白酶激活的见解。
Blood Adv. 2025 Apr 22;9(8):1940-1951. doi: 10.1182/bloodadvances.2025015842.
2
First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men.首例评估靶向凝血因子 XI 和因子 XIa 的抗体 BAY 1831865 在健康男性中的安全性、药效学和药代动力学的随机研究。
J Thromb Haemost. 2022 Jul;20(7):1684-1695. doi: 10.1111/jth.15744. Epub 2022 May 20.
3
Role of platelets in regulating activated coagulation factor XI activity.

本文引用的文献

1
Factor XII and uPAR upregulate neutrophil functions to influence wound healing.因子 XII 和 uPAR 上调中性粒细胞功能以影响伤口愈合。
J Clin Invest. 2018 Mar 1;128(3):944-959. doi: 10.1172/JCI92880. Epub 2018 Jan 29.
2
An update on factor XI structure and function.因子 XI 结构与功能的最新研究进展。
Thromb Res. 2018 Jan;161:94-105. doi: 10.1016/j.thromres.2017.10.008. Epub 2017 Oct 10.
3
An essential role of high-molecular-weight kininogen in endotoxemia.高分子量激肽原在内毒素血症中的重要作用。
血小板在调节激活的凝血因子 XI 活性中的作用。
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C365-C374. doi: 10.1152/ajpcell.00056.2020. Epub 2021 Jan 20.
4
The rebirth of the contact pathway: a new therapeutic target.接触途径的重生:一个新的治疗靶点。
Curr Opin Hematol. 2020 Sep;27(5):311-319. doi: 10.1097/MOH.0000000000000603.
5
The contact pathway and sepsis.接触途径与脓毒症
Res Pract Thromb Haemost. 2019 May 23;3(3):331-339. doi: 10.1002/rth2.12217. eCollection 2019 Jul.
6
Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib.白细胞整合素 Mac-1 I 结构域与血小板糖蛋白 Ib 相互作用的结构基础。
Blood Adv. 2019 May 14;3(9):1450-1459. doi: 10.1182/bloodadvances.2018027011.
7
Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.血浆激肽释放酶结构揭示与因子 XI 相比,苹果域盘旋转构象。
J Thromb Haemost. 2019 May;17(5):759-770. doi: 10.1111/jth.14418. Epub 2019 Mar 19.
J Exp Med. 2017 Sep 4;214(9):2649-2670. doi: 10.1084/jem.20161900. Epub 2017 Aug 9.
4
Factor XII Contact Activation.凝血因子 XII 接触激活。
Semin Thromb Hemost. 2017 Nov;43(8):814-826. doi: 10.1055/s-0036-1598003. Epub 2017 Mar 27.
5
Factors XI and XII as Targets for New Anticoagulants.作为新型抗凝剂靶点的因子XI和因子XII。
Front Med (Lausanne). 2017 Feb 24;4:19. doi: 10.3389/fmed.2017.00019. eCollection 2017.
6
Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension.血小板定位型 FXI 在动脉高血压中促进血管凝血-炎症循环。
Sci Transl Med. 2017 Feb 1;9(375). doi: 10.1126/scitranslmed.aah4923.
7
Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.血浆激肽释放酶介导中风后小鼠组织纤溶酶原激活剂治疗引起的脑出血和水肿。
Blood. 2017 Apr 20;129(16):2280-2290. doi: 10.1182/blood-2016-09-740670. Epub 2017 Jan 27.
8
Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP.血浆激肽释放酶通过亚阈值剂量的ADP增强血小板聚集反应。
Biochimie. 2017 Apr;135:72-81. doi: 10.1016/j.biochi.2017.01.010. Epub 2017 Jan 20.
9
Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.CLEC-2 缺乏的小鼠对深静脉血栓形成具有抵抗力。
Blood. 2017 Apr 6;129(14):2013-2020. doi: 10.1182/blood-2016-09-742999. Epub 2017 Jan 19.
10
Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.单链凝血因子XII的蛋白水解特性:触发接触激活的一种机制。
Blood. 2017 Mar 16;129(11):1527-1537. doi: 10.1182/blood-2016-10-744110. Epub 2017 Jan 9.